Latest Period
n/a
Security Snapshot
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) Institutional Ownership
CUSIP: 90466Y103
13F Institutional Holders and Ownership History from Q3 2021 to Q2 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.75
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- UNCY on Nasdaq
- Shares outstanding
- 18,578,488
- Price per share
- $0.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 90466Y103.
- Latest finished 13F holder period is not available.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 29 to 0 between Q1 2025 and Q2 2025.
- Reported value moved from $34,451,479 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
90466Y103
Latest holder period
n/a
13F holders
13D/G owners
6
CIK / CUSIP context first
UNCY full holder history
Unicycive Therapeutics, Inc. SEC filings
Unicycive Therapeutics, Inc. company facts
Unicycive Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 90466Y103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
UNCY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 10% | $38,405,889 | 60,961,729 | Vivo Opportunity Fund Holdings, L.P. | 31 Mar 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $8,370,042 | +$1,112,366 | 13,285,781 | +15% | RA Capital Management, L.P. | 31 Mar 2025 |
| GREAT POINT PARTNERS LLC | 10% | $7,228,095 | 11,473,166 | Great Point Partners, LLC | 31 Dec 2024 | |||
| Walleye Capital LLC | 4.8% | $3,150,000 | 5,000,000 | Walleye Capital LLC | 31 Dec 2024 | |||
| Nantahala Capital Partners Limited Partnership | 2.8% | -62% | $1,895,683 | -$3,073,653 | 3,009,021 | -62% | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 19 Dec 2024 |
| Nantahala Capital Management, LLC | 10% | 0% | $1,391,993 | +$466,046 | 1,855,991 | +50% | Nantahala Capital Management, LLC | 30 Sep 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
16
Latest
n/a
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$34,451,479 | $0.75 | 0 |
| 2025 Q1 | 59,926,848 | $34,451,479 | -$1,351,595 | $0.57 | 29 |
| 2024 Q4 | 61,700,962 | $49,002,183 | +$12,116,344 | $0.79 | 31 |
| 2024 Q3 | 46,786,564 | $19,084,180 | +$10,632,565 | $0.41 | 28 |
| 2024 Q2 | 18,997,259 | $9,519,281 | -$954,361 | $0.50 | 23 |
| 2024 Q1 | 14,441,576 | $19,929,234 | +$6,691,650 | $1.38 | 21 |
| 2023 Q4 | 13,030,671 | $11,307,131 | -$1,007,258 | $0.87 | 16 |
| 2023 Q3 | 14,192,814 | $12,205,365 | +$11,249,090 | $0.86 | 16 |
| 2023 Q2 | 1,074,486 | $1,375,341 | -$1,380,929 | $1.28 | 15 |
| 2023 Q1 | 1,686,443 | $3,541,351 | +$1,994,377 | $2.10 | 13 |
| 2022 Q4 | 795,253 | $428,290 | -$100,167 | $0.54 | 9 |
| 2022 Q3 | 968,202 | $571,000 | -$128,238 | $0.59 | 11 |
| 2022 Q2 | 1,194,501 | $992,000 | +$8,181 | $0.83 | 14 |
| 2022 Q1 | 1,150,630 | $1,475,000 | +$40,949 | $1.28 | 11 |
| 2021 Q4 | 1,115,406 | $2,298,000 | -$90,197 | $2.06 | 9 |
| 2021 Q3 | 1,065,645 | $3,015,000 | +$3,015,000 | $2.83 | 9 |